In addition, CD8 + T cell-derived EVs contain miR-298-5p, FasL, TNF-α, and PD-L1 to reduce the formation of mesenchymal tumor stromal cells including mesenchymal stem cells and CAFs, thereby mitigating melanoma progression [232]. This evidence concerns the gene CD8A and melanoma.